Cipla in the pink of health

Cipla rose 1.09% to Rs 436.10 at 14:43 IST on BSE after the company said that India Ratings & Research, a Fitch Group company has assigned a Long-Term Issuer Rating of 'IND AAA' to the company.

The announcement was made during trading hours today, 25 September 2013.

Meanwhile, the S&P BSE Sensex was down 114.30 points or 0.57% at 19,805.91.

On BSE, 66,000 shares were traded in the counter as against average daily volume of 1.35 lakh shares in the past one quarter.

The stock rose as much as 1.48% at the day's high of Rs 437.80 so far during the day. The stock lost as much as 0.49% at the day's low of Rs 429.25 so far during the day. The stock had hit a record high of Rs 450 on 16 September 2013. The stock had hit a 52-week low of Rs 352.80 on 24 September 2012.

The stock had outperformed the market over the past one month till 24 September 2013, jumping 8.94% compared with the Sensex's 7.56% surge. The scrip had also outperformed the market in past one quarter, surging 13.53% as against Sensex's 7.44% gain.

The large-cap company has equity capital of Rs 160.58 crore. Face value per share is Rs 2.

Cipla's consolidated net profit rose 10.3% to Rs 485.35 crore on 19.4% growth in net sales to Rs 2307.71 crore in Q1 June 2013 over Q1 June 2012.

Cipla is a pharmaceutical company. With over 34 manufacturing units across the country, Cipla manufactures over 2000 products in 65 therapies. With a turnover of over $1.5 billion, Cipla serves doctors and patients in over 170 countries.

Powered by Capital Market - Live News